全文获取类型
收费全文 | 971290篇 |
免费 | 78934篇 |
国内免费 | 2251篇 |
专业分类
耳鼻咽喉 | 14309篇 |
儿科学 | 27640篇 |
妇产科学 | 27004篇 |
基础医学 | 138271篇 |
口腔科学 | 27633篇 |
临床医学 | 86384篇 |
内科学 | 187306篇 |
皮肤病学 | 18721篇 |
神经病学 | 80742篇 |
特种医学 | 39039篇 |
外国民族医学 | 175篇 |
外科学 | 152017篇 |
综合类 | 26361篇 |
现状与发展 | 3篇 |
一般理论 | 423篇 |
预防医学 | 76987篇 |
眼科学 | 23023篇 |
药学 | 72474篇 |
2篇 | |
中国医学 | 1747篇 |
肿瘤学 | 52214篇 |
出版年
2018年 | 9420篇 |
2016年 | 8297篇 |
2015年 | 9850篇 |
2014年 | 14161篇 |
2013年 | 21526篇 |
2012年 | 29484篇 |
2011年 | 31111篇 |
2010年 | 18014篇 |
2009年 | 17044篇 |
2008年 | 29576篇 |
2007年 | 32114篇 |
2006年 | 31843篇 |
2005年 | 31728篇 |
2004年 | 30892篇 |
2003年 | 29898篇 |
2002年 | 28627篇 |
2001年 | 36882篇 |
2000年 | 37321篇 |
1999年 | 32006篇 |
1998年 | 10742篇 |
1997年 | 9817篇 |
1996年 | 9499篇 |
1995年 | 9029篇 |
1994年 | 8552篇 |
1992年 | 27336篇 |
1991年 | 26721篇 |
1990年 | 26229篇 |
1989年 | 25235篇 |
1988年 | 23725篇 |
1987年 | 23375篇 |
1986年 | 22230篇 |
1985年 | 21685篇 |
1984年 | 17113篇 |
1983年 | 14740篇 |
1982年 | 9861篇 |
1981年 | 9120篇 |
1980年 | 8519篇 |
1979年 | 17158篇 |
1978年 | 12638篇 |
1977年 | 10676篇 |
1976年 | 9722篇 |
1975年 | 10512篇 |
1974年 | 12971篇 |
1973年 | 12411篇 |
1972年 | 11738篇 |
1971年 | 10804篇 |
1970年 | 10349篇 |
1969年 | 10021篇 |
1968年 | 8976篇 |
1967年 | 8305篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Vestibular function laboratories utilize a multitude of diagnostic instruments to evaluate a dizzy patient. Caloric irrigators, oculomotor stimuli, and rotational chairs produce a stimulus whose accuracy is required for the patient response to be accurate. Careful attention to everything from cleanliness of equipment to threshold adjustments determine on a daily basis if patient data are going to be correct and useful. Instrumentation specifications that change with time such as speed and temperature must periodically be checked using calibrated instruments. 相似文献
52.
53.
54.
55.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
56.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
57.
Paul J. Devlin Brian W. McCrindle James K. Kirklin Eugene H. Blackstone William M. DeCampli Christopher A. Caldarone Ali Dodge-Khatami Pirooz Eghtesady James M. Meza Peter J. Gruber Kristine J. Guleserian Bahaaladin Alsoufi Linda M. Lambert James E. OBrien Erle H. Austin Jeffrey P. Jacobs Tara Karamlou 《The Journal of thoracic and cardiovascular surgery》2019,157(2):684-695.e8
Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献58.
59.
60.